The Tumor Microenvironment: Signal Transduction

Xianhong Zhang,Haijun Ma,Yue Gao,Yabing Liang,Yitian Du,Shuailin Hao,Ting Ni

DOI: https://doi.org/10.3390/biom14040438

IF: 6.064

2024-04-05

Biomolecules

Abstract:In the challenging tumor microenvironment (TME), tumors coexist with diverse stromal cell types. During tumor progression and metastasis, a reciprocal interaction occurs between cancer cells and their environment. These interactions involve ongoing and evolving paracrine and proximal signaling. Intrinsic signal transduction in tumors drives processes such as malignant transformation, epithelial-mesenchymal transition, immune evasion, and tumor cell metastasis. In addition, cancer cells embedded in the tumor microenvironment undergo metabolic reprogramming. Their metabolites, serving as signaling molecules, engage in metabolic communication with diverse matrix components. These metabolites act as direct regulators of carcinogenic pathways, thereby activating signaling cascades that contribute to cancer progression. Hence, gaining insights into the intrinsic signal transduction of tumors and the signaling communication between tumor cells and various matrix components within the tumor microenvironment may reveal novel therapeutic targets. In this review, we initially examine the development of the tumor microenvironment. Subsequently, we delineate the oncogenic signaling pathways within tumor cells and elucidate the reciprocal communication between these pathways and the tumor microenvironment. Finally, we give an overview of the effect of signal transduction within the tumor microenvironment on tumor metabolism and tumor immunity.

biochemistry & molecular biology

What problem does this paper attempt to address?

The paper primarily explores the signaling mechanisms within the Tumor Microenvironment (TME) and their impact on tumor development. Tumor cells coexist with various types of stromal cells in the complex TME. During tumor progression and metastasis, there are interactions between cancer cells and their environment, involving continuously changing paracrine and juxtacrine signaling. The paper emphasizes how signaling within the tumor drives processes such as malignant transformation, epithelial-mesenchymal transition, immune evasion, and metastasis of tumor cells.

Additionally, cancer cells embedded in the TME undergo metabolic reprogramming, and the metabolic products they generate act as signaling molecules involved in metabolic communication, directly regulating oncogenic pathways and thereby activating signaling cascades that promote cancer progression. Therefore, a deep understanding of intra-tumoral signaling and the signal exchange between tumor cells and various stromal components in the TME may reveal new therapeutic targets.

In summary, this review article first discusses the development of the TME, then elaborates on the oncogenic signaling pathways within tumor cells and their interactions with the TME. Finally, the article outlines the impact of signaling within the TME on tumor metabolism and tumor immunity. Through these studies, the authors aim to uncover the mechanisms of the complex signaling networks in the TME, providing a theoretical foundation for the development of novel anti-cancer therapies.